BCAX
BICARA THERAPEUTICS INC
Latest close $25.47 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 27, 2026 filed · 27d Initial Schedule 13G | Initial Schedule 13G | 3.5M | 12.00% | $29.69 | $27.81 | $25.47 |
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed Apr 8, 2026 filed · 8d Schedule 13G amendment | Reported accumulation | 6.6M +3.4M | 12.00% 0.00 pts | $19.89 | $21.61 | $25.47 |
| T. Rowe Price Investment Management CIK0001897612 | Dec 31, 2025 observed Feb 17, 2026 filed · 48d Initial Schedule 13G | Initial Schedule 13G | 3.2M | 12.00% | $16.83 | $14.08 | $25.47 |